SCHEMBL10265083

SCHEMBL10265083

COC(=O)c1sc(I)cc1NC(C)=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.58
KDM4E B2RXH2 3/20 0.58
MAPT P10636 3/20 0.58
LMNA P02545 2/20 0.58
HPGD P15428 4/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
GLA P06280 1/20 0.45
GAA P10253 1/20 0.45
PPARG P37231 1/20 0.45
NCOA2 Q15596 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
MAPK14 Q16539 4/20 0.42
RAF1 P04049 4/20 0.41
MAPK13 O15264 1/20 0.41
MAPK12 P53778 1/20 0.41
MAPK11 Q15759 1/20 0.41
PIK3CA P42336 1/20 0.40
PIK3CB P42338 1/20 0.40
PIK3CG P48736 1/20 0.40
PI4KB Q9UBF8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24131808 0.81 HPGD (0.42) ALDH1A1KDM4EMAPTLMNAHPGD
SCHEMBL4147003 0.81 HPGD (0.42) ALDH1A1KDM4EMAPTLMNAHPGD
SCHEMBL23012335 0.81 ALDH1A1 (0.60) ALDH1A1KDM4EMAPTLMNAHPGD
SCHEMBL4781956 0.80 RAF1 (0.42) ALDH1A1KDM4EMAPTLMNAHPGD
SCHEMBL21411362 0.80 ALDH1A1 (0.58) ALDH1A1KDM4EMAPTLMNAHPGD
SCHEMBL12247516 0.80 MAPT (0.58) ALDH1A1KDM4EMAPTLMNAHPGD
SCHEMBL10740064 0.80 MAPK14 (0.62) ALDH1A1KDM4EMAPTLMNAHPGD
SCHEMBL4151548 0.79 RAF1 (0.39) ALDH1A1KDM4EMAPTLMNAHPGD
SCHEMBL21411359 0.78 ALDH1A1 (0.56) ALDH1A1KDM4EMAPTLMNAHPGD
SCHEMBL13425471 0.78 RAF1 (0.65) MAPK14RAF1MAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012006055-A2 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-01-12 WO disclosed